Cancers, Free Full-Text

Por um escritor misterioso

Descrição

Ubiquitin-like, containing PHD and RING finger domain, (UHRF) family members are overexpressed putative oncogenes in several cancer types. We evaluated the protein abundance of UHRF family members in acute leukemia. A marked overexpression of UHRF1 protein was observed in ALL compared with AML. An analysis of human leukemia transcriptomic datasets revealed concordant overexpression of UHRF1 in B-Cell and T-Cell ALL compared with CLL, AML, and CML. In-vitro studies demonstrated reduced cell viability with siRNA-mediated knockdown of UHRF1 in both B-ALL and T-ALL, associated with reduced c-Myc protein expression. Mechanistic studies indicated that UHRF1 directly interacts with c-Myc, enabling ALL expansion via the CDK4/6-phosphoRb axis. Our findings highlight a previously unknown role of UHRF1 in regulating c-Myc protein expression and implicate UHRF1 as a potential therapeutic target in ALL.
Cancers, Free Full-Text
Pan-cancer whole-genome comparison of primary and metastatic solid
Cancers, Free Full-Text
PDF) Combination of tumor markers predicts progression and
Cancers, Free Full-Text
Cancer Free – Heaven Sent Greeting Cards
Cancers, Free Full-Text
Frailty and prognosis in lung cancer: systematic review and meta
Cancers, Free Full-Text
19 Oral Cancer Photos, Pictures And Background Images For Free
Cancers, Free Full-Text
Pancreatic Cancer Action Network – Research, Patient Support
Cancers, Free Full-Text
Cancer Financial Support Organizations
Cancers, Free Full-Text
Multimodal analysis of cell-free DNA whole-methylome sequencing
Cancers, Free Full-Text
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical
Cancers, Free Full-Text
Cancer in Lymph Nodes May Help Tumors Metastasize - NCI
Cancers, Free Full-Text
Hypercalcemia and treated breast cancers: The diagnostic dilemma
Cancers, Free Full-Text
cancer free Poster for Sale by NiceShirtY
Cancers, Free Full-Text
Cancer Svg, Cancer Survivor Svg Graphic by artinrhythm · Creative
Cancers, Free Full-Text
Event-free Survival with Pembrolizumab in Early Triple-Negative
de por adulto (o preço varia de acordo com o tamanho do grupo)